Akorn, Inc. is a niche pharmaceutical company that develops, manufactures, and markets generic, branded prescription, animal health, and consumer health products. We specialize in difficult-to-manufacture alternate sterile and non-sterile dosage forms including: ophthalmics, injectables, oral liquids, oral solids, otics, topicals, inhalations, and nasal sprays.
Akorn has fully dedicated Research and Development facilities in Vernon Hills, IL; Warminster, PA; and Copiague, NY that insure a robust and continuous pipeline of new products. In 2014, the Company completed the acquisition of Hi-Tech Pharmacal Co., Inc. and VersaPharm Inc. further expanding our manufacturing capabilities in our Decatur, IL; Somerset, NJ; Amityville, NY; and Paonta Sahib, India facilities. Akorn markets prodcuts to retail pharmacy chains, ophthalmologists, optometrists, physicians, veterinarians, hospitals, clinics, wholesalers, distributors, group purchasing organizations, and government agencies.